Psoriasis Active Not Recruiting Phase 3 Trials for Secukinumab (DB09029)

Also known as: PSORIASIS / Psoriasis unspecified / Psoriasis, unspecified

IndicationStatusPhase
DBCOND0013339 (Psoriasis)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03090100A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type PsoriasisTreatment